Kabbage Maria, Trimeche Mounir, Ben Nasr Hela, Hammann Philippe, Kuhn Lauriane, Hamrita Bechr, Chaieb Anouar, Chouchane Lotfi, Chahed Karim
Laboratoire d'Immuno-Oncologie Moléculaire, Faculté de Médecine de Monastir, Monastir, Tunisia.
Tumour Biol. 2012 Dec;33(6):2279-88. doi: 10.1007/s13277-012-0490-4. Epub 2012 Sep 13.
This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.
本研究旨在评估αB-晶状体蛋白在浸润性导管乳腺癌(IDCA)中的表达及其预后意义。通过二维电泳-基质辅助激光解吸/电离飞行时间质谱分析结合免疫组化方法,我们评估了αB-晶状体蛋白在IDCA以及其他类型乳腺肿瘤(浸润性小叶癌、髓样癌和导管原位癌)中的表达。还研究了αB-晶状体蛋白表达与乳腺癌临床病理参数之间的相关性。蛋白质组学分析显示,与相邻非肿瘤组织相比,IDCA肿瘤中αB-晶状体蛋白表达增加。在51个肿瘤标本中进一步证实了这种分子伴侣的过表达。然而,统计分析显示,αB-晶状体蛋白表达与疾病的临床病理参数(肿瘤分期、患者年龄、激素受体、SBR分级和淋巴结转移)之间无显著相关性。本研究证明了IDCA组织中αB-晶状体蛋白的上调,这可能突出其在乳腺癌发生中的可能作用。然而,我们的研究结果不支持这种分子伴侣参与该疾病的进展。